Menu
Close

Syndax pharma tie-up

lse:azn

#1

The announced tie up between Syndax pharma and ANZ has pushed Syndax up 10% today.

This could be the breakthrough in cancer treatment, injecting the tumour with a combination of the ANZ and Syndax drugs, which kills off the tumour and activates the immune system to kill off all secondary tumours as well.

90% of mice were cured with only one treatment, and all the rest were cured with a second treatment. That is all mice were cured! Pretty impressive, and not too expensive.

I believe the ANZ drug is already approved for human use and the Syndax drug is undergoing human trials.

Good news,
Regards,
Happy


#2

That’s great news on the fighting cancer front. And even better news if you mean AZN and not ANZ!!!


#3

Yep! No banks involved.

Happy


#4

If you’re happy, I’m happy.